TY - JOUR A1 - Sotoudeh, Houman A1 - Shafaat, Omid A1 - Bernstock, Joshua D. A1 - Brooks, David A1 - Elsayed, Galal A1 - Chen, Jason A. A1 - Szerip, Paul A1 - Chagoya, Gustavo A1 - Geßler, Florian A1 - Sotoudeh, Ehsan A1 - Shafaat, Amir A1 - Friedman, Gregory K. T1 - Artificial intelligence in the management of glioma: Era of personalized medicine T2 - Frontiers in oncology N2 - Purpose: Artificial intelligence (AI) has accelerated novel discoveries across multiple disciplines including medicine. Clinical medicine suffers from a lack of AI-based applications, potentially due to lack of awareness of AI methodology. Future collaboration between computer scientists and clinicians is critical to maximize the benefits of transformative technology in this field for patients. To illustrate, we describe AI-based advances in the diagnosis and management of gliomas, the most common primary central nervous system (CNS) malignancy. Methods: Presented is a succinct description of foundational concepts of AI approaches and their relevance to clinical medicine, geared toward clinicians without computer science backgrounds. We also review novel AI approaches in the diagnosis and management of glioma. Results: Novel AI approaches in gliomas have been developed to predict the grading and genomics from imaging, automate the diagnosis from histopathology, and provide insight into prognosis. Conclusion: Novel AI approaches offer acceptable performance in gliomas. Further investigation is necessary to improve the methodology and determine the full clinical utility of these novel approaches. KW - glioma KW - artificial intelligence KW - neural network KW - deep neural network KW - convolution neural network KW - support vector machines Y1 - 2019 UR - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/51867 UR - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-518678 SN - 2234-943X N1 - Copyright © 2019 Sotoudeh, Shafaat, Bernstock, Brooks, Elsayed, Chen, Szerip, Chagoya, Gessler, Sotoudeh, Shafaat and Friedman. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. VL - 9 IS - Art. 768 SP - 1 EP - 11 PB - Frontiers Media CY - Lausanne ER -